Please login to the form below

Not currently logged in
Email:
Password:

Quintiles partners to improve patient care

Quintiles has signed a collaborative agreement to help drive innovation, improve patient care and increase efficiency in early stage clinical research

Quintiles has signed a collaborative agreement with Guy's and St Thomas' NHS Foundation Trust and King's College London to help drive innovation, improve patient care and increase efficiency in early stage clinical research.

As part of the agreement, the biopharmaceutical services company, has commissioned a research facility with 30 beds, for both patients and healthy volunteers involved in research within Guy's Hospital in London. The facility, to be named Quintiles Drug Research Unit, will be completed in early 2010 and will increase Quintiles' capacity to conduct proof-of-concept programmes that help biopharmaceutical companies develop better medicines faster.

Eddie Caffrey, senior vice president, Global Phase I, Quintiles, said: "The biopharmaceutical industry must bring new drugs to market faster and with greater predictability to address declining research and development productivity. The smartest move is to invest in intelligent, early-stage development because, when done well, it has significant impact on speed and cost of the overall development process."

Ron Kerr, chief executive of Guy's and St Thomas' NHS Foundation Trust said: "We want to deliver the best possible care to our patients, and we know that aligning clinical service excellence with translational research has been shown to be one of the most effective ways to do this. We're excited by the potential of this collaboration as it will lead to a smoother and faster clinical trials process, ensuring our patients and local people are among the first to benefit from any new discoveries."

Professor Robert Lechler, vice-principal (health), King's College London and Director of King's Health Partners, said: "King's College London's important partnership with Quintiles and Guy's and St Thomas' NHS Foundation Trust, one of our Academic Health Sciences Centre (AHSC) partners, is exactly the sort of collaboration we expect to see at the heart of King's Health Partners."

Lechler added: "Through this collaboration and the significant investments we have already made to develop first class clinical research facilities, we will create a powerful 'experimental medicine' hub across four floors of the Guy's Hospital Tower, allowing us to harness the expertise of our world class scientists and clinicians to drive new discoveries in medicine and clinical treatment."

27th October 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics